GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of the IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML
- Status
- COMPLETED
- Phase
- PHASE1
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients
- Status
- UNKNOWN
- Phase
- PHASE2
ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Multiple CAR-T Cell Therapy Targeting AML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid Leukaemia
- Status
- UNKNOWN
- Phase
- PHASE1
AML Expressive Writing
- Status
- TERMINATED
- Phase
- NA
Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML
- Status
- TERMINATED
- Phase
- PHASE2
Combining Active and Passive DNA Hypomethylation
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT
- Status
- UNKNOWN
- Phase
- PHASE2